Prothena Corporation plc

NasdaqGS:PRTA Stock Report

Market Cap: US$1.1b

Prothena Dividend

Dividend criteria checks 0/6

Prothena does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$2.74
Dividend yield forecast in 3Y0%

Recent dividend updates

No updates

Recent updates

Prothena: Alzheimer's Data Update In 2024 Could Move The Needle

Feb 23

Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%

Feb 08
Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%

Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?

Dec 20
Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?

Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business

Nov 24
Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business

Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk

Oct 27
Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk

Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

Aug 25
Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today

May 10
What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today

We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Apr 23
We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook

Mar 01
Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook

We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate

Dec 28
We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate

Prothena: Paying A Premium To Cover All The Alzheimer's Bases

Sep 29

Prothena GAAP EPS of -$0.88 misses by $0.31

Aug 08

Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates

May 08
Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates

Are Prothena Corporation plc (NASDAQ:PRTA) Investors Paying Above The Intrinsic Value?

Jan 10
Are Prothena Corporation plc (NASDAQ:PRTA) Investors Paying Above The Intrinsic Value?

Prothena: A Biotech Company With A Promising Pipeline

Dec 01

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if PRTA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PRTA's dividend payments have been increasing.


Dividend Yield vs Market

Prothena Dividend Yield vs Market
How does PRTA dividend yield compare to the market?
SegmentDividend Yield
Company (PRTA)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.7%
Industry Average (Biotechs)2.8%
Analyst forecast in 3 Years (PRTA)0%

Notable Dividend: Unable to evaluate PRTA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PRTA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate PRTA's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as PRTA has not reported any payouts.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.